Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$10.2B
168M shares
52-week range
$34.60 – $72.88
71% from low
Sector
INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Exchange
NASDAQ
CS
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.
www.cognex.comNo one on the platform currently holds CGNX.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 868,058 | $42.5M |
| Bridgewater Associatesas of 2026-03-31 | 83,570 | $4.1M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-08-20 | $0.0850 | 2026-09-03 |
| 2026-05-21 | $0.0850 | 2026-06-04 |
| 2026-02-26 | $0.0850 | 2026-03-12 |
| 2025-11-13 | $0.0850 | 2025-11-28 |
| 2025-08-14 | $0.0800 | 2025-08-28 |
| 2025-05-15 | $0.0800 | 2025-05-29 |
| 2025-02-27 | $0.0800 | 2025-03-13 |
| 2024-11-14 | $0.0800 | 2024-11-29 |
| 2024-08-15 | $0.0750 | 2024-08-29 |
| 2024-05-15 | $0.0750 | 2024-05-30 |
No one on the platform has traded CGNX yet.
| 2024-02-28 | $0.0750 | 2024-03-14 |
| 2023-11-16 | $0.0750 | 2023-12-01 |
| Execution date | Ratio |
|---|---|
| 2017-11-16 | 2-for-1 |
| 2013-09-17 | 2-for-1 |
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$CGNX is trading strong around $66.89 right now! $CGON is trading strong around $75.10 right now! Goldman Sachs hiked Cognex to $91 alongside bullish bumps from Cantor, Needham, and Truist; meanwhile, Truist and Piper Sandler pushed CG Oncology targets up to $85. With institutional upgrades rolling in, avoid chasing green candles blindly and scale into key support dips! Are these target hikes setting up the ultimate breakout rally for both names?
View on StockTwits ↗@Bernelius85 Any others beyond $AMBA $AMBQ $CGNX $ALNT $OUST that I should be thinking about?
View on StockTwits ↗$CGNX reported 0.45 EPS and 291.00 revenue for Q2. http://www.estimize.com/intro/cgnx?chart=historical&metric_name=eps&utm_content=CGNX&utm
View on StockTwits ↗$CGNX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.43 up 79.17% YoY • Reported revenue of $291.26M up 16.93% YoY • Cognex Corporation issued full-year 2026 guidance anticipating strong double-digit revenue growth and significant year-over-year expansion in profitability, with revenue expected to range between $1,130 million and $1,150 million for 2026.
View on StockTwits ↗The biggest AI opportunities won’t come from watching one stock. They come from understanding the rotation. My framework for tracking the AI ecosystem: Physical AI $BOTZ → $ISRG $CGNX $TSLA The key insight: Capital rotates before the headlines arrive. When one part of the AI ecosystem gets crowded, money often moves into the next bottleneck. That’s why I track sector strength and weakness instead of chasing yesterday’s winners. The AI buildout is a multi-year cycle. The goal is finding where capital is moving before everyone notices. Follow my profile for more AI infrastructure, sector rotation, and next-generation technology analysis.
View on StockTwits ↗$CGNX reports after the close, Estimize Consensus +0.03 EPS and +4.20M Revs compared to WS http://www.estimize.com/cgnx/fq2-2026?utm_conten
View on StockTwits ↗My approach? Follow the ETFs. When multiple AI sectors break out of long downtrends at the same time, it can signal a broader cycle shift. Key areas to watch: $BOTZ — Robotics & Physical AI $TSLA $CGNX $ISRG The AI super cycle is still in its early stages. The next decade could require massive investment in. Volatility is part of every major market cycle. Don’t let short-term pullbacks distract you from the long-term buildout. Breakouts, confirmation, and patience matter.
View on StockTwits ↗$CEG $NVDA $CGNX $MP $RRX The next major AI investment opportunity may not look like an AI stock at all. As humanoid robots move closer to commercial production, investors naturally gravitate toward the companies building the machines everyone can see—Tesla, NVIDIA, and the growing list of robotics startups racing to develop increasingly capable robots. But there is another layer to this revolution that could prove just as important, and potentially more diversified. Every humanoid robot, regardless of who ultimately wins the market, needs motors, precision gears, actuators, sensors, cameras, magnets, semiconductors, and advanced manufacturing. The artificial intelligence may provide the brain, but an... https://www.wizeinvesting.com/p/what-500-a-month-in-ceg-could-become-over-5-years
View on StockTwits ↗No A+ setups. No forced trades. I haven’t posted many setups over the last two weeks. Not because I don’t want to. There simply haven’t been enough high-conviction opportunities. I don’t post setups just to stay active. I only share ideas where the risk/reward and technical structure stand out. That said, I’m starting to see larger bases forming across the market and within specific groups. These setups may need more time to mature, but the watchlist is growing: $DELL $LASR $AME $CGNX $HPE Patience is part of the process. The best trades often come when the setup is ready—not when we force ourselves to find one. Watching closely.
View on StockTwits ↗$CGNX in at 65.50 very solid company moving forward into physical ai/robotics the next couple of quarters/ years.
View on StockTwits ↗$CGNX Catching a bid in sympathy with AMBA buyout offer?
View on StockTwits ↗$CGNX Monthly — Breakout Meets Reversal $CGNX broke out of a multi-year base in 2026, nearly tripling off its 2025 low ($25) to a high near $95–100, reclaiming the $55 level that had capped price since 2018. This month it gave much of that back — closing at $60.42, down 16.6% from the open, on heavy volume. Still, the pullback held above the old $55 ceiling (low: $57.70), which is now the key line in the sand. RSI(14) at 59 shows momentum cooling but not breaking down. The bigger tell: CGNX:$SPX relative strength (0.0081) remains near multi-year lows, so this move has barely dented years of underperformance vs. the broader market. Bottom line: $55 is the level that decides it — stay above and the breakout stays alive with room to retest highs; a monthly close below puts CGNX right back in its old range.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.1B | +13.2% | $1.50 | $1.42–$1.63 | 41.2× | 13 |
| 2027 | $1.2B | +8.9% | $1.80 | $1.72–$1.94 | 34.1× | 13 |
| 2028 | $1.3B | +10.4% | $2.22 | $1.93–$2.61 | 27.8× | 6 |
| 2029 | $1.5B | +14.9% | $2.50 | $2.34–$2.63 | 24.6× | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | $0.42 | $0.45 | +6.2% |
| 2026-05-06 | $0.25 | $0.34 | +36.9% |
| 2026-02-11 | $0.22 | $0.27 | +22.7% |
| 2025-10-29 | $0.27 | $0.33 | +22.2% |
| 2025-07-30 | $0.23 | $0.25 | +8.7% |
| 2025-04-30 | $0.13 | $0.16 | +23.1% |
| 2025-02-12 | $0.15 | $0.20 | +33.3% |
| 2024-10-30 | $0.19 |
| $0.20 |
| +5.3% |
| $11.4B |
| — |
| NOVTNovanta Inc. | $167.25 | +0.13% | $6.0B | — |
| OLEDUniversal Display Corporation | $90.96 | -1.14% | $4.2B | — |
Source: Financial Modeling Prep · peers by sector/industry